Semaglutide is one molecule sold under three names — and that’s where most of the confusion starts. Ozempic and Wegovy are the same drug at different doses, both made by Novo Nordisk. Compounded semaglutide is the same active ingredient made by a different kind of pharmacy. Below is what each version actually is, who it’s for, and what it costs right now.
What Semaglutide Is
Semaglutide is a GLP-1 receptor agonist — a synthetic version of the gut hormone GLP-1 that your body releases after meals. It signals the pancreas to release insulin, slows stomach emptying, and tells the brain you’re full. Higher, longer-lasting doses than your body makes naturally is what turns satiety into meaningful appetite suppression.
It’s the longest-running weight loss GLP-1 on the market in its current form. Wegovy was FDA-approved for chronic weight management in adults in 2021. Ozempic was approved for type 2 diabetes in 2017 and is widely used off-label for weight loss.
For the full class context — including how semaglutide compares to tirzepatide and the newer molecules — see the full GLP-1 medication class.
Brand-Name vs Compounded Semaglutide
Three versions are clinically available in 2026:
- Ozempic (semaglutide injection) — FDA-approved for type 2 diabetes. Doses: 0.25, 0.5, 1, and 2 mg weekly. Self-pay list price hovers around $1,000/month, though insurance and savings cards can drop that significantly for diabetes patients.
- Wegovy (semaglutide injection) — FDA-approved for chronic weight management. Doses: 0.25, 0.5, 1, 1.7, and 2.4 mg weekly. Novo’s self-pay program (NovoCare) lists Wegovy at $499/month for cash-pay patients in 2026.
- Compounded semaglutide — Made by 503A or 503B pharmacies, not Novo. Cash-pay only, typically $129–$399/month. Available because of a now-resolved drug shortage; the 503B Bulks List proposal could shrink availability after the June 29, 2026 comment period closes.
There’s also an oral semaglutide pill (Rybelsus for diabetes; a new Wegovy oral form approved in late 2025), but the injection is what almost everyone means when they say “semaglutide.”
Who Semaglutide Is For
The honest answer is: people who are overweight or obese and want meaningful appetite suppression with the longest safety track record of any GLP-1 weight loss drug. Tirzepatide (the dual GIP/GLP-1 molecule in Mounjaro and Zepbound) has been outperforming semaglutide on weight loss endpoints in head-to-head trials, but it’s three years younger as a weight-loss-approved drug. If you want the longer evidence base, semaglutide is the conservative pick.
It’s also the only GLP-1 with strong cardiovascular outcomes data (the SELECT trial showed 20% reduction in major adverse cardiac events in overweight patients without diabetes). If you have cardiovascular risk factors, that data is harder to ignore.
What Semaglutide Costs in 2026
| Path | Monthly cost | Notes |
|---|---|---|
| Wegovy via insurance | $0–$50 copay | If your plan covers it. Most commercial plans cover Wegovy with prior auth + BMI requirements. |
| NovoCare cash-pay Wegovy | $499/mo | Direct from Novo for self-pay patients |
| Ozempic via insurance (diabetes) | $0–$50 copay | T2D coverage is standard |
| Compounded semaglutide | $129–$399/mo | Cash-pay only. See the cheapest semaglutide programs for current pricing across providers. |
| Retail Wegovy without insurance | $1,300+/mo | Walgreens/CVS list price; rarely the right path |
The cheapest legitimate path for most uninsured patients is compounded semaglutide from a vetted 503A or 503B pharmacy. The best compounded GLP-1 providers guide breaks down which programs we vetted as patients and which we flagged.
How to Get Semaglutide
Three routes:
- Through your existing doctor + insurance. Best if you have a covered plan. Bring your BMI numbers, comorbidity history, and ask specifically about Wegovy coverage. PA paperwork is standard.
- Direct from Novo via NovoCare. $499/month cash-pay Wegovy with no insurance involvement. Straightforward but more expensive than compounded.
- Through a telehealth program. Most prescribe compounded semaglutide; some prescribe brand-name and help with PA. See the best telehealth GLP-1 programs for the current ranked list.
What to Watch For
Side effects: nausea, constipation, fatigue, mild GI upset for the first 4–8 weeks. These almost always fade once your body adjusts to a steady dose. About 5–10% of patients can’t tolerate the GI side effects at all.
Cost cliff: if you’re starting on compounded because of price, plan for what happens if 503B compounding gets restricted after June 29, 2026. The fallback is NovoCare at $499/month or insurance with PA. Build that into the decision instead of finding out the hard way.
Pharmacy verification: not every “compounded semaglutide” provider works with a properly licensed pharmacy. Always check that the program names its pharmacy partner and that the pharmacy holds a current, unencumbered license.
Where Next
- Looking for the lowest price? Cheapest semaglutide providers ranked by patient experience
- Don’t know which GLP-1 yet? The full GLP-1 medication class guide
- Want the cheapest path across all GLP-1s? Cheapest GLP-1 medications
- No insurance? GLP-1 without insurance: 2026 cash-pay playbook